175 related articles for article (PubMed ID: 17304647)
1. N-of-1 trial of low-dose methotrexate and/or prednisolone in lieu of anti-CCP, MRI, or ultrasound, as first option in suspected rheumatoid arthritis?
Pincus T; Huizinga TW; Yazici Y
J Rheumatol; 2007 Feb; 34(2):250-2. PubMed ID: 17304647
[No Abstract] [Full Text] [Related]
2. Intensive combination treatment regimens, including prednisolone, are effective in treating patients with early rheumatoid arthritis regardless of additional etanercept: 1-year results of the COBRA-light open-label, randomised, non-inferiority trial.
ter Wee MM; den Uyl D; Boers M; Kerstens P; Nurmohamed M; van Schaardenburg D; Voskuyl AE; Lems WF
Ann Rheum Dis; 2015 Jun; 74(6):1233-40. PubMed ID: 24818633
[TBL] [Abstract][Full Text] [Related]
3. Is attenuated COBRA treatment strategy (COBRA-light) non-inferior or not non-inferior than original COBRA strategy?
Akar S; Tinazli M
Clin Exp Rheumatol; 2014; 32(6 Suppl 87):S-18. PubMed ID: 25327510
[No Abstract] [Full Text] [Related]
4. [Evidence-based treatment of methotrexate-resistant rheumatoid arthritis. Combinations of conventional disease-modifying antirheumatic agents].
Schnabel A; Gross WL
Dtsch Med Wochenschr; 2003 Jan; 128(4):147-9. PubMed ID: 12589584
[No Abstract] [Full Text] [Related]
5. Corticosteroids in rheumatoid arthritis.
Haslock I
Br J Hosp Med; 1996 Jun 19-Jul 9; 56(1):50. PubMed ID: 8831016
[No Abstract] [Full Text] [Related]
6. [Arthritis of the atlanto-axial joint with inflammatory neck pain as a primary manifestation of seronegative rheumatoid arthritis].
Haeusler U; Dybowski F; Wittkaemper TA; Kisters K; Godolias G; Braun J
Dtsch Med Wochenschr; 2010 Sep; 135(36):1729-32. PubMed ID: 20812156
[TBL] [Abstract][Full Text] [Related]
7. Short- and long-term efficacy of intra-articular injections with betamethasone as part of a treat-to-target strategy in early rheumatoid arthritis: impact of joint area, repeated injections, MRI findings, anti-CCP, IgM-RF and CRP.
Hetland ML; Østergaard M; Ejbjerg B; Jacobsen S; Stengaard-Pedersen K; Junker P; Lottenburger T; Hansen I; Andersen LS; Tarp U; Svendsen A; Pedersen JK; Skjødt H; Ellingsen T; Lindegaard H; Pødenphant J; Hørslev-Petersen K;
Ann Rheum Dis; 2012 Jun; 71(6):851-6. PubMed ID: 22302316
[TBL] [Abstract][Full Text] [Related]
8. A treat-to-target strategy with methotrexate and intra-articular triamcinolone with or without adalimumab effectively reduces MRI synovitis, osteitis and tenosynovitis and halts structural damage progression in early rheumatoid arthritis: results from the OPERA randomised controlled trial.
Axelsen MB; Eshed I; Hørslev-Petersen K; Stengaard-Pedersen K; Hetland ML; Møller J; Junker P; Pødenphant J; Schlemmer A; Ellingsen T; Ahlquist P; Lindegaard H; Linauskas A; Dam MY; Hansen I; Horn HC; Ammitzbøll CG; Jørgensen A; Krintel SB; Raun J; Krogh NS; Johansen JS; Østergaard M;
Ann Rheum Dis; 2015 May; 74(5):867-75. PubMed ID: 24412895
[TBL] [Abstract][Full Text] [Related]
9. Predictors of response to methotrexate in early DMARD naive rheumatoid arthritis: results from the initial open-label phase of the SWEFOT trial.
Saevarsdottir S; Wallin H; Seddighzadeh M; Ernestam S; Geborek P; Petersson IF; Bratt J; van Vollenhoven RF;
Ann Rheum Dis; 2011 Mar; 70(3):469-75. PubMed ID: 21149498
[TBL] [Abstract][Full Text] [Related]
10. Early rheumatoid arthritis: combination therapy with disease-modifying antirheumatic drugs and low-dose glucocorticoids?
Kirwan J
Nat Clin Pract Rheumatol; 2006 Apr; 2(4):182-3. PubMed ID: 16932680
[No Abstract] [Full Text] [Related]
11. Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate: a two-year randomized trial.
Svensson B; Boonen A; Albertsson K; van der Heijde D; Keller C; Hafström I
Arthritis Rheum; 2005 Nov; 52(11):3360-70. PubMed ID: 16255010
[TBL] [Abstract][Full Text] [Related]
12. Delay in imaging versus clinical response: a rationale for prolonged treatment with anti-tumor necrosis factor medication in early rheumatoid arthritis.
Wakefield RJ; Freeston JE; Hensor EM; Bryer D; Quinn MA; Emery P
Arthritis Rheum; 2007 Dec; 57(8):1564-7. PubMed ID: 18050231
[No Abstract] [Full Text] [Related]
13. [Autoimmune pancreatitis associated with rheumatoid arthritis: successful combination therapy with steroids and methotrexate].
Mustak M; Boltuch-Sherif J; Horvath-Mechtler B; Kowalski-Bodzenta J; Erlacher L
Dtsch Med Wochenschr; 2011 Sep; 136(37):1842-4. PubMed ID: 21898275
[TBL] [Abstract][Full Text] [Related]
14. Initial high-dose prednisolone combination therapy using COBRA and COBRA-light in early rheumatoid arthritis.
Rasch LA; van Tuyl LH; Lems WF; Boers M
Neuroimmunomodulation; 2015; 22(1-2):51-6. PubMed ID: 25227967
[TBL] [Abstract][Full Text] [Related]
15. COBRA combination therapy in daily practice--getting back to the future.
Boers M
Rheumatology (Oxford); 2008 Jan; 47(1):1-2. PubMed ID: 18077485
[No Abstract] [Full Text] [Related]
16. Early local swelling and tenderness are associated with large-joint damage after 8 years of treatment to target in patients with recent-onset rheumatoid arthritis.
van den Broek M; Dirven L; Kroon HM; Kloppenburg M; Ronday HK; Peeters AJ; Kerstens PJ; Huizinga TW; Lems WF; Allaart CF
J Rheumatol; 2013 May; 40(5):624-9. PubMed ID: 23547212
[TBL] [Abstract][Full Text] [Related]
17. Early suppression of disease activity is essential for maintenance of work capacity in patients with recent-onset rheumatoid arthritis: five-year experience from the FIN-RACo trial.
Puolakka K; Kautiainen H; Möttönen T; Hannonen P; Korpela M; Hakala M; Järvinen P; Ahonen J; Forsberg S; Leirisalo-Repo M;
Arthritis Rheum; 2005 Jan; 52(1):36-41. PubMed ID: 15641055
[TBL] [Abstract][Full Text] [Related]
18. [Combination therapy in early rheumatoid arthritis: the COBRA study].
Boers M; Verhoeven AC; van der Linden S
Ned Tijdschr Geneeskd; 1997 Dec; 141(50):2428-32. PubMed ID: 9555126
[TBL] [Abstract][Full Text] [Related]
19. Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: results from a twelve-month randomized, double-blind, placebo-controlled trial.
Quinn MA; Conaghan PG; O'Connor PJ; Karim Z; Greenstein A; Brown A; Brown C; Fraser A; Jarret S; Emery P
Arthritis Rheum; 2005 Jan; 52(1):27-35. PubMed ID: 15641102
[TBL] [Abstract][Full Text] [Related]
20. Why are Dutch rheumatologists reluctant to use the COBRA treatment strategy in early rheumatoid arthritis?
van Tuyl LH; Plass AM; Lems WF; Voskuyl AE; Dijkmans BA; Boers M
Ann Rheum Dis; 2007 Jul; 66(7):974-6. PubMed ID: 17392349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
